135 related articles for article (PubMed ID: 8492125)
1. Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Hadjiconstantinou M; Wemlinger TA; Sylvia CP; Hubble JP; Neff NH
J Neurochem; 1993 Jun; 60(6):2175-80. PubMed ID: 8492125
[TBL] [Abstract][Full Text] [Related]
2. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
Neff NH; Wemlinger TA; Hadjiconstantinou M
J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
4. Aromatic L-amino acid decarboxylase is modulated by D1 dopamine receptors in rat retina.
Rossetti ZL; Silvia CP; Krajnc D; Neff NH; Hadjiconstantinou M
J Neurochem; 1990 Mar; 54(3):787-91. PubMed ID: 2137529
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.
Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
Brain Res; 1999 Jun; 830(2):237-45. PubMed ID: 10366680
[TBL] [Abstract][Full Text] [Related]
6. Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum.
Neff NH; Wemlinger TA; Duchemin AM; Hadjiconstantinou M
J Pharmacol Exp Ther; 2006 May; 317(2):480-7. PubMed ID: 16415089
[TBL] [Abstract][Full Text] [Related]
7. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
King JM; Muthian G; Mackey V; Smith M; Charlton C
Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
[TBL] [Abstract][Full Text] [Related]
8. Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
Yee RE; Huang SC; Stout DB; Irwin I; Shoghi-Jadid K; Togaski DM; DeLanney LE; Langston JW; Satyamurthy N; Farahani KF; Phelps ME; Barrio JR
J Neurochem; 2000 Mar; 74(3):1147-57. PubMed ID: 10693947
[TBL] [Abstract][Full Text] [Related]
9. Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
Zhu MY; Juorio AV; Paterson IA; Boulton AA
Eur J Pharmacol; 1993 Jul; 238(2-3):157-64. PubMed ID: 8104805
[TBL] [Abstract][Full Text] [Related]
10. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
Fisher A; Biggs CS; Eradiri O; Starr MS
Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
[TBL] [Abstract][Full Text] [Related]
11. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.
Hadjiconstantinou M; Neff NH
CNS Neurosci Ther; 2008; 14(4):340-51. PubMed ID: 19040557
[TBL] [Abstract][Full Text] [Related]
12. Evidence for cyclic AMP-mediated increase of aromatic L-amino acid decarboxylase activity in the striatum and midbrain.
Young EA; Neff NH; Hadjiconstantinou M
J Neurochem; 1993 Jun; 60(6):2331-3. PubMed ID: 8388038
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester administration transiently increases aromatic L-amino acid decarboxylase activity of the mouse striatum and midbrain.
Young EA; Neff NH; Hadjiconstantinou M
J Neurochem; 1994 Aug; 63(2):694-7. PubMed ID: 8035193
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
Pifl C; Nanoff C; Schingnitz G; Schütz W; Hornykiewicz O
J Neurochem; 1992 Jun; 58(6):1997-2004. PubMed ID: 1349341
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between biochemical and behavioral recovery in MPTP-treated mice.
Weihmuller FB; Hadjiconstantinou M; Bruno JP
Pharmacol Biochem Behav; 1989 Sep; 34(1):113-7. PubMed ID: 2696981
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain.
Zhu MY; Juorio AV; Paterson IA; Boulton AA
J Neurochem; 1992 Feb; 58(2):636-41. PubMed ID: 1729407
[TBL] [Abstract][Full Text] [Related]
18. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
[TBL] [Abstract][Full Text] [Related]
19. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
20. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
